NCT02726035

Evaluation of Naltrexone as a Treatment for Self-injurious Behavior

Evaluation of Naltrexone as a Treatment for Self-Injurious Behavior

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Western Michigan University School of Medicine · Academic / Other
• Sex: All
• Age: 13 Years
• Healthy volunteers: Not accepted

Summary

The proposed study examines the effect of oral naltrexone on self-injurious behavior (SIB) in adolescents and adults of normal intelligence.

Detailed description

The proposed study examines the effect of oral naltrexone on self-injurious behavior (SIB) in adolescents and adults of normal intelligence. It is designed as a pilot study and will provide preliminary data for a larger scale clinical trial if found to be effective in the pilot study.

Conditions

• Self-injurious Behavior
• Self Mutilation

Interventions

Type	Name	Description
DRUG	Naltrexone	oral naltrexone 50 mg daily
OTHER	Placebo	oral placebo (appearing identical to naltrexone) once daily

Timeline

• Start date: 2014-02-22
• Primary completion: 2015-06-30
• Completion: 2017-01-04
• First posted: 2016-04-01
• Last updated: 2017-11-06

Locations

1 site across 1 country: United States